A 48-year-old woman with poorly controlled type 2 diabetes mellitus (HbA1c 9.8%) undergoes elective hysterectomy. On postoperative day 12, the surgical wound shows delayed healing with minimal granulation tissue formation and persistent serosanguinous drainage. The patient is afebrile and hemodynamically stable. Which investigation would best assess the adequacy of wound healing and identify any underlying collagen deposition abnormality?

Explanation

## Investigation for Assessing Delayed Wound Healing and Collagen Deposition ### Clinical Context The patient presents with delayed wound healing on postoperative day 12, characterized by minimal granulation tissue and persistent drainage. Hyperglycemia (HbA1c 9.8%) impairs multiple phases of wound healing, particularly collagen synthesis and cross-linking. Direct tissue assessment is needed to evaluate the proliferative phase and collagen deposition. ### Why Wound Biopsy with Histopathology is Correct **Key Point:** Wound biopsy with histopathological examination and collagen analysis (using special stains like Masson's trichrome or Verhoeff-Van Gieson) is the gold standard for directly assessing collagen deposition, fibroblast activity, and the adequacy of the proliferative phase. **High-Yield:** Histopathology reveals: 1. **Collagen quantity and organization** — assess adequacy of Type I and Type III collagen deposition 2. **Fibroblast activity** — presence and maturity of fibroblasts indicate proliferative phase progression 3. **Neovascularization** — capillary formation and angiogenesis status 4. **Inflammatory cell infiltration** — persistent inflammation may indicate impaired healing 5. **Epithelialization** — degree of re-epithelialization and basement membrane reformation **Clinical Pearl:** In diabetic patients, histology often reveals reduced collagen synthesis, delayed fibroblast proliferation, and impaired angiogenesis — all contributing to delayed wound healing. Special stains quantify collagen and assess cross-linking defects. ### Phases of Wound Healing and Biopsy Timing | Phase | Timeline | Histological Features | Biopsy Finding in Diabetes | | --- | --- | --- | --- | | **Inflammatory** | 0–5 days | Neutrophils → macrophages; fibrin clot | Prolonged inflammation | | **Proliferative** | 5–21 days | Fibroblasts, collagen deposition, angiogenesis, epithelialization | **Reduced collagen, fewer fibroblasts** | | **Remodeling** | 21 days–2 years | Collagen cross-linking, scar maturation | Delayed remodeling | At day 12, the patient should be in the **proliferative phase**. Biopsy directly assesses whether collagen deposition is adequate. ### Why Other Investigations Are Inadequate **Serum albumin and total protein:** Non-specific nutritional markers. While malnutrition impairs healing, serum levels do not directly assess tissue collagen deposition or fibroblast activity. They reflect systemic protein status, not local wound healing physiology. **Tissue Doppler ultrasound:** Assesses blood flow and perfusion but does not evaluate collagen synthesis, fibroblast activity, or histological adequacy of the proliferative phase. It is useful for assessing vascular insufficiency, not collagen deposition. **Serum vitamin C and zinc levels:** While deficiencies impair wound healing (vitamin C is a cofactor for collagen hydroxylation; zinc is essential for fibroblast proliferation), serum levels are non-specific and do not directly assess tissue collagen or healing adequacy. Supplementation is empiric; biopsy confirms actual tissue pathology. **Mnemonic: CHOP** — Collagen, Histology, Organization, Proliferation — the four elements directly assessed by wound biopsy.